Research
Hormonal
Modifying the glycemic index of a high-quality dietary pattern (like DASH) does not improve cardiovascular risk factors or insulin sensitivity compared to a high-GI version of the same pattern.
Do not assume that choosing 'low GI' versions of healthy foods (like low-GI pasta or bread) offers extra cardiovascular benefits over standard versions if the overall diet is already healthy. Focus on the quality of the entire diet (e.g., DASH or Mediterranean patterns) rather than optimizing for glycemic index.
StrongRefutesHIGH confidence
a DASH-type diet containing low-GI foods compared with high-GI foods 'does not improve CVD risk factors and may in fact reduce insulin sensitivity'
Why this rating
Based on a randomized controlled trial (OmniCarb) cited in the paper.
Source
Perspective: The Glycemic Index Falls Short as a Carbohydrate Food Quality Indicator to Improve Diet Quality
Jill Nicholls · Frontiers in Nutrition · 2022
DOI 10.3389/fnut.2022.896333
narrative_reviewCited 15×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Using the Glycemic Index (GI) as a primary indicator for carbohydrate quality fails to improve diet quality or Dietary Guidelines adherence because it ignores nutrient density and food context.Good
- Postprandial glycemic responses to identical meals are highly variable between individuals but predictable within individuals based on personal characteristics.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →